1. Peng Li , Bin Wang , Xi Chen , Ziyun Lin , Gang Li*, Yu Lu* , Haihong Huang *.Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis.Bioorg Chem.2022.131.106250.SCI |
2. Xi Chen , Yuanyuan Li , Bin Wang , Yu Lu *.Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis.Curr Microbiol..2022.79(7).205.SCI |
3. Ning Wang , Shaochen Guo , Haiting Liu , Yangming Ding , Rong Yao , Zhongquan Liu , Hui Zhu , Xi Chen 1, Xinting Yang , Xiaoyou Chen , Yu Lu *.Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.Xenobiotica.2022.52(5).520-526.SCI |
4. Fengjiao Du# , Aiying Xing# , Zihui Li , Liping Pan , Hongyan Jia , Boping Du , Qi Sun , Rongrong Wei , Zhongquan Liu* , Zongde Zhang*.Rapid Detection of Mycobacterium tuberculosis in Pleural Fluid Using Resuscitation-Promoting Factor-Based Thin Layer Agar Culture Method.Front Microbiol..2022.13.803521.SCI |
5. Wenjing Liu , Yuanyu Huang *.Cell membrane-engineered nanoparticles for cancer therapy.J Mater Chem B.2022.10(37).7161-7172.SCI |
6. Hongyi Zhao , Yongxin Gao , Wei Li , Li Sheng , Keli Cui , Bin Wang , Lei Fu , Meng Gao , Ziyun Lin , Xiaowen Zou , Mary Jackson , Haihong Huang* , Yu Lu* , Dongfeng Zhang *.Design, Synthesis, and Biological Evaluation of Pyrrole-2- carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis.J Med Chem..2022.65(15) .10534-10553.SCI |
7. Wenjing Liu , Zetan Fan , Lele Li *, Mengyuan Li *.DNA-Based Nanoprobes for Simultaneous Detection of Telomerase and Correlated Biomolecules.Chembiochem.2022.23(21).e202200307 .SCI |
8. Wenqiang Zhou #, Wenjuan Nie #, Qingfeng Wang , Wenhui Shi , Yang Yang , Qi Li , Hui Zhu , Zhongquan Liu , Yangming Ding , Yu Lu *, Naihui Chu*.Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis.Int J Antimicrob Agents..2022.59(6).106589.SCI |
9. Rui Shi , Bin Wang , Giovanni Stelitano , Xiaomei Wu , Yuanyuan Shan , Yue Wu , Xin Wang , Laurent R Chiarelli *, Yu Lu *, Chunhua Qiao *.Development of 6‑Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.ACS Med Chem Lett.2022.13(4).593-598.SCI |
10. Rongfei Qin #, Pengxu Wang #, Bin Wang , Lei Fu , Sarah M Batt , Gurdyal S Besra , Chengwei Wu , Yanan Wang , Haihong Huang *, Yu Lu *, Gang Li *.Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.European Journal of Medicinal Chemistry.2022.231.114145.SCI |
11. Yangming Ding #, Hui Zhu #, Lei Fu , Weiyan Zhang , Bin Wang , Shaochen Guo , Xi Chen , Ning Wang , Haiting Liu , Yu Lu *.Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis.Antimicrob Agents Chemother..2022.66(9).e0065822.SCI |
12. Rong Yao #, Bin Wang #, Lei Fu , Lei Li , Kejun You , Yong-Guo Li *, Yu Lu *.Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis.Microbiol Spectr.2022.10(1).e0247721.SCI |
13. Xiaofu Zhang , Xi Chen , Bin Wang , Lei Fu , Fengmin Huo , Tianhui Gao 1, Yu Pang , Yu Lu *, Qi Li *.Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis.MICROBIAL DRUG RESISTANCE.2022.28(3).280-287.SCI |
14. Zhang X, Chen X, Wang B, Fu L, Huo F, Gao T, Pang Y, Lu Y*, Li Q*.Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis.Microb Drug Resist .2022.Mar 28(3).280-287.SCI |
15. Qin R, Wang P, Wang B, Fu L, Batt SM, Besra GS, Wu C, Wang Y, Huang H*, Lu Y*, Li G*.Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.Eur J Med Chem .2022.Mar 5.114145.SCI |
16. Yao R, Wang B, Fu L, Li L, You K, Li YG, Lu Y*.Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis.Microbiol Spectr ..2022.10(1).e0247721.SCI |
17. Zhu Hui, Fu Lei, Wang Bin, Chen Xi, Zhao Jiaojie, Huang Hairong, Lu Yu*.Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis in Different Administration Intervals in Mouse Tuberculosis Models..Antimicrob Agents Chemother.2021.64(4).e02164-20.SCI |
18. Peng Li, Bin Wang, Lei Fu, Kaijing Guo, Chen Ma, Baolian Wang, Ziyun Lin, Gang Li, Haihong Huang, Yu Lu*.Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis.Eur J Med Chem.2021.222.113603.SCI |
19. Hui Chen, Bin Wang, Peng Li, Hong Yan, Gang Li, Haihong Huang, Yu Lu*.The optimization and characterization of functionalized sulfonamides derived from sulfaphenazole against Mycobacterium tuberculosis with reduced CYP 2C9 inhibition.Bioorg. Med. Chem. Lett..2021.40.127924.SCI |
20. Apeng Wang , Shijie Xu, Yun Chai, Guimin Xia, Bin Wang, Kai Lv, Chao Ma, Dan Wang, Aoyu Wang, Xiaoyu Qin, Mingliang Liu, Yu Lu*.Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.Eur J Med Chem.2021.218.113398.SCI |
21. HuiZhu, Li Xie, Zhongquan Liu, Bin Wang, Mengqui Gao, Yu Lu*.Population pharmacokinetics of bedaquiline in patients with drug-resistant TB.INT J TUBERC LUNG DIS.2021.25(12).1006–1012.SCI |
22. Dongguang Fan, Yu Lu, Giovanni Stelitano, Karin Savková, Rui Shi, Stanislav Huszár, Quanquan Han, Katarína Mikušová, Laurent R. Chiarelli, Yu Lu*, Chunhua Qiao.Structural and Activity Relationships of 6‑Sulfonyl-8- Nitrobenzothiazinones as Antitubercular Agents.Journal of Medicinal Chemistry.2021.64.e00974-21.SCI |
23. Yuanyuan Li, Lei Fu, Weiyan Zhang, Xi Chen, Yu Lu*.The Transcription Factor Rv1453 Regulates the Expression of qor and Confers Resistant to Clofazimine in Mycobacterium tuberculosis.Infection and Drug Resistance.2021.14.3937-3948.SCI |
24. Apeng Wang, Shijie Xu, Yun Chai, Guimin Xia, Bin Wang, Kai Lv, Dan Wang, Xiaoyu Qin, Bin Jiang, Wenhao Wu, Mingliang Liu*, Yu Lu*.Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazolehybrids as new antitubercular agents.Bioorganic & Medicinal Chemistry.2021.53.116529.SCI |
25. Shaochen Guo, Bin Wang, Lei Fu , Xi Chen, Weiyan Zhang, Haihong Huang*, Yu Lu*.In vitro and in vivo 1 activity of oxazolidinone candidate OTB-658 against Mycobacterium tuberculosis.Antimicrob Agents Chemother.2021.65(11).e00974-21.SCI |
26. 赵皎洁,付雷,王彬,张蕾,胡明豪,陆宇*.抗结核药物体外药代动力学/药效学研究模型的建立及应用.中国防痨杂志.2020.42(4).372-379.核心期刊 |
27. Ping Liu , Shiyong Fan , Bin Wang , Ruiyuan Cao , Xiaokui Wang , Song Li , Yu Lu *, Wu Zhong .Design, synthesis and biological evaluation of novel triaryldimethylaminobutan-2-ol derivatives against Mycobacterium tuberculosis.Bioorganic Chemistry.2020.102. .SCI |
28. Minghao Hu , Lei Fu , Bin Wang, Jian Xu , Shaochen Guo , Jiaojie Zhao, Yuanyuan Li , Xiaoyou Chen* , Yu Lu *.Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro.Infect Drug Resist.2020.13.1751-1761.SCI |
29. Hongyi Zhao , Bin Wang , Lei Fu, Gang Li , Haijia Lu , Yuke Liu , Li Sheng , Yan Li , Baoxi Zhang , Yang Lu , Chen Ma , Haihong Huang , Dongfeng Zhang , Yu Lu *.Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis.J Med Chem.2020.63(17).9316-9339.SCI |
30. Apeng Wang , Yu Lu *, Kai Lv , Chao Ma , Shijie Xu , Bin Wang , Aoyu Wang , Guimin Xia , Mingliang Liu .Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine.Bioorg Chem.2020.102.104135.SCI |
31. 张静, 陈曦, 王彬, 付雷, 陆宇*, 陈效友*.改良单叠氮丙啶2荧光定量RFV法的建立及其检测抗结核药物活性的价值.中国防痨杂志.2020.42(5).472-480.核心期刊 |
32. 张蕾,陆宇*.一线抗结核药物致药物性肝损伤机制研究进展.临床药物治疗杂志.2020.18(7).21-25.核心期刊 |
33. Apeng Wang , Chao Ma , Yun Chai , Xiujun Liu , Kai Lv , Lei Fu , Bin Wang , Xuedong Jia , Mingliang Liu , Yu Lu *.Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.Eur J Med Chem.2020.200.112409.SCI |
34. Peng Li , Bin Wang , Gang Li , Lei Fu , Dongfeng Zhang , Ziyun Lin , Haihong Huang , Yu Lu *.Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis.Eur J Med Chem.2020.206. .SCI |
35. 高天慧,舒薇,高静韬,陆宇*,李琦*.254例耐药肺结核患者克拉霉素耐药情况及影响因素分析.中国防痨杂志.2020.42(3).259-265.核心期刊 |
36. 张叶,李媛媛,徐建,陈曦,王彬,付雷,陆宇*.吡法齐明抗耐药结核分枝杆菌作用机制的初步研究.中国防痨杂志.2019.41(11).1160-1166.核心期刊 |
37. 张叶,朱慧,付雷,王彬,郭少晨,陈曦,刘忠泉,黄海洪,Tianjian Yang,陆宇*.Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo.Antimicrob Agents Chemother.2019.63(7).02496-18.SCI |
38. 徐建,王彬,付雷,朱慧,郭少晨,黄海洪, 尹大力, 张叶,陆宇*.In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis.Antimicrob Agents Chemother.2019.63(5). 02155-18.SCI |
39. Apeng Wang, Hongjian Wang, Yunhe Geng, Lei Fu, Jian Gu, Bin Wang, Kai Lv,Zeyu Tao , Chao Ma, Mingliang Liu*,陆宇*.Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.Bioorganic & Medicinal Chemistry .2019.27(5).813-821.SCI |
40. Hongjian Wang, Kai Lv,XiaoningLi, BoWang, ApengWang, ZeyuTao, YunheGeng, Bin Wang, MenghaoHuang, Huiyuan Guo,Mingliang Liu,陆宇*.Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives.Chinese Chemical Letters.2019.30(2).413-416.SCI |
41. Apeng Wang, Kai Lv,LinhuLi, HongtaoLiu,ZeyuTao,Bin Wang,ChaoMa, XicanMa, BingHan, AoyuWang,Mingliang Liu,陆宇*.Design, synthesis and biological activity of N-(2-phenoxy)ethylimidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.European Journal of Medicinal Chemistry.2019.178.715-725.SCI |
42. Dongfeng Zhang,Yun Lin, Xi Chen, Wenting Zhao, Dongni Chen, Meng Gao, Qinglin Wang,Bin Wang,Haihong Huang, Yongjun Lu, 陆宇*.Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold.Bioorganic Chemistry.2019.85.229-239.SCI |
43. 张叶,陆宇*.亚胺吩嗪类药物抗结核作用研究进展.中华结核和呼吸杂志.2019.42(2).118-121.核心期刊 |
44. Apeng Wang, Kai Lv,Zeyu Tao, Jian Gu, Lei Fu, Baojie Wan, Scott G. Franzblau, Chao Ma, Xican Ma, Bing Han, Aoyu Wang, Shijie Xu, Mingliang Liu,陆宇*.Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.European Journal of Medicinal Chemistry .2019.181. .SCI |
45. 陈曦,刘忠泉,王彬, 朱慧, 付雷, 李媛媛,陆宇*.14种抗结核药物的巨噬细胞内活性的比较研究.中国防痨杂志.2019.41(9).993-998.核心期刊 |
46. Apeng Wang, Kai Lv,Zeyu Tao,Lei Fu, Hongtao Liu, Bin Wang, Chao Ma, Hongjian Wang, Xican Ma, Bing Han, Aoyu Wang, Kai Zhang,Mingliang Liu,陆宇*.hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.European Journal of Medicinal Chemistry.2019.179.208-217.SCI |
47. Hongjian Wang, Apeng Wang,Jian Gu, Lei Fu, Kai Lv, Chao Ma, Zeyu Tao, Bin Wang, Huiyuan GuoMingliang Liu,陆宇*.Synthesis and antitubercular evaluation of reduced lipophilic imidazo [1,2-a]pyridine-3-carboxamide derivatives.European Journal of Medicinal Chemistry .2019.165.11-17.SCI |
48. 赵皎洁,陆宇*.抗结核药物药代动力学/药效学的研究及进展.中国防痨杂志.2019.41(6).700-704.核心期刊 |
49. 王彬,付雷,徐建,郭少晨,朱慧,陆宇*.圣露丸的抗结核作用初步实验研究.中国防痨杂志.2018.40(1).80-83.核心期刊 |
50. Apeng Wang ,, Yang Yang , Yangsheng Jun , Bin Wang, Kai Lv , Mingliang Liu, Huiyuan Guo ,Yu Lu*.Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents.Bioorganic & Medicinal Chemistry.2018.2018(26).2073-2084.SCI |
51. Kai Lv , 1, Zeyu Tao , Qian Liu , Lu Yang a, Bin Wang, Shuo Wu , Apeng Wang,Menghao Huang , Mingliang Liu *, Yu Lu *.Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.European Journal of Medicinal Chemistry .2018.2018(151).1-8.SCI |
52. Li L, Jin Y, Wang B, Yang Z, Liu M, Guo H, Zhang J, Lu Y*..A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study..Chem Biol Drug Des..2018.91(3).769-780.SCI |
53. Wang A, Li W, Wang B, Lv K, Wang H, Liu M, Guo H, Lu Y*..Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents..Future Med Chem.2018.10(17).2059-2068.SCI |
54. Li L, Lv K, Yang Y, Sun J, Tao Z, Wang A, Wang B, Wang H, Geng Y, Liu M, Guo H, Lu Y*..Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents..ACS Med Chem Lett.2018.9(7).741-745.SCI |
55. Zhu H#, Guo SC#, Liu ZQ, Wang B, Fu L, Chu NH, Lu Y*..Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.INT J TUBERC LUNG DIS.2018.22(8).931-936.SCI |
56. Wang A, Huang G, Wang B, Lv K, Wang H, Tao Z, Liu M, Guo H, Lu Y*..Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties..Bioorg Med Chem Lett.2018.28(17).2945-2948.SCI |
57. Zhang Y, Zhu H, Yang X, Guo S, Liang Q, Lu Y*, Chen X*.Serum vitamin D level and vitamin D receptor genotypes may be associated with tuberculosis clinical characteristics: A case-control study.Medicine (Baltimore).2018.(97)30.e11732.SCI |
58. 陆宇.治疗药物监测与药物基因组学在优化抗结核治疗中的作用.临床药物治疗杂志.2018.16(4).23-28.核心期刊 |
59. 郭少晨,朱慧,郭超,王彬,刘忠泉,徐建,付雷,陈效友,陆宇*.909例结核病患者一线抗结核药物血药浓度监测结果分析.中国防痨杂志.2018.40(7).744-749.核心期刊 |
60. Peng Li, Bin Wang ,Xinwei Zhang ,Sarah M. Batt , Gurdyal S. Besra,Tingting Zhang,, Chen Ma,Dongfeng Zhang, Ziyun Lin, Gang Li,Haihong Huang*, Yu Lu*.Identification of Novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzonthiazinones.Eur J Med Chem.2018.160.157-170.SCI |
61. 冉飞勇,付雷,王彬,郭少晨,陆宇*,陈效友*.维生素D在豚鼠结核感染中的辅助治疗作用评价.中国防痨杂志.2018.40(5).512-518.核心期刊 |
62. 胡明豪,王彬,付雷,徐建,陆宇*.体外诱导获取对利奈唑胺耐药的MTB菌株及其稳定性研究.中国防痨杂志.2017.39(4).397-401.核心期刊 |
63. Zhao H, Lu Y#, Sheng L1, Yuan Z, Wang B, Wang W, Li Y, Ma C, Wang X, Zhang* , Huang H*.Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis.ACS Med Chem Lett..2017.8(5).533-537.SCI |
64. Xu J, Wang B, Hu M, Huo F, Guo S, Jing W, Nuermberger E, Lu Y*.Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis.Antimicrob. Agents Chemother.2017. AAC.2017.3.20.AAC.00239-17.SCI |
65. Rui Zhang,Kai Lv, Bin Wang,Linhu Li,Bo Wang,Mingliang Liu,* Huiyuan Guo,Apeng Wang,Yu Lu*.Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety.RSC Advances.2017.2017,7.1480-1483.SCI |
66. 胡明豪,徐建,王彬,付雷,陆宇*.结核分枝杆菌对PA-824耐药的体外诱导及稳定性研究.中国抗生素杂志.2017.42(2).144-148.核心期刊 |
67. Jian Xu, Ju-xian Wang, Jin-ming Zhou, Chang-liang Xu, Bin Huang, Yun Xing, Bin Wang, Rui Luo, Yu-cheng Wang, Xue-fu You, Yu Lu * and Li-yan Yu .A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity.Scientific RepoRts .2017. Jul 11;7(1):5093.s41598-017-04108-7..SCI |
68. Hongyi Zhao, Yu Lu#, Li Sheng, Zishuo Yuan, Bin Wang, Weiping Wang, Yan Li, Chen Ma, Xiaoliang Wang, Dongfeng Zhang, and Haihong Huang.Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis .ACS Medicinal Chemistry Letters.2017.8(5).533-537.SCI |
69. Kai Lv , Linhu Li , Bo Wang, Mingliang Liu, Bin Wang, Weiyi Shen, Huiyuan Guo,Yu Lu *.Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.European Journal of Medicinal Chemistry .2017.2017:137.117-125. |
70. Linhu Li, Zhuorong Li , Mingliang Liu *, Weiyi Shen, Bin Wang, Huiyuan Guo, Yu Lu*.Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.Molecules.2016.21, 49.doi:10.3390/molecules21010049.SCI |
71. Ju Huang , Minghua Wang, Bin Wang, Zhaoyang Wua, Mingliang Liu,Lianshun Feng,Jun Zhang, Xiaoning Li,Yang Yang,Yu Lu*.Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety.Bioorg. Med. Chem. Lett.2016.26(2016).2262-2267.SCI |
72. 张叶,郭少晨,朱慧,郭超,陆宇*,陈效友*.UPLC-MS/MS法测定人血浆中25羟基维生素D的浓度及其应用 .中国药房.2016.27(14).1907-1910.核心期刊 |
73. Wu Z, Lu Y#, Li L, Zhao R, Wang B, Lv K, Liu M, You X*..Identification of N (2-Phenoxyethyl)imidazo[1,2 a]pyridine-3-carboxamides as New Antituberculosis Agents.ACS Medicinal Chemistry Letters .2016.7(12).1130-1133.SCI |
74. 胡明豪,陆宇*.硝基咪唑类抗结核新药研究进展.中国防痨杂志.2016.38(11).990-994.核心期刊 |
75. 陆宇.实验技术人员在研究生培养中的作用探讨.基础医学教育.2015.17(1).81-83.核心期刊 |
76. Ju Huang,Hongtao Liu ,Mingliang Liu , Rui Zhang, Linhu Li, Bin Wang, Minghua Wang,Chunlan Wang, Yu Lu*.Synthesis, antimycobacterial and antibacterial activity of l-[(1R,2S)-2-fluorocyclopropyl]naphthyridone derivatives containing an oxime-functionalized pyrrolidine moiety.Bioorg. Med. Chem. Lett.2015.25.5058-5063.SCI |
77. Tingting Zhang,Weiyi Shen,Mingliang Liu*, Rui Zhang,Minghua Wang,Linhu Li, Bin Wang, Huiyuan Guo,Yu Lu *.Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4- (cyclopropylanimo)methylpyrrolidine moiety. European Journal of Medicinal Chemistry.2015.104.73-85.SCI |
78. Hui Zhu, Shao-Chen Guo, Lan-Hu Hao, Cheng-Cheng Liu, Bin Wang, Lei Fu, Ming-Ting Chen, Lin Zhou, Jun-Ying Chi, Wen Yang, Wen-Juan Nie, Yu Lu*.Relative bioavailability of rifampicin in four Chinese fixed-dose combinations compared with rifampicin in free combinations.Chin Med J.2015.128(4).433-437.SCI |
79. 左小淑,王彬,徐建,付雷,陆宇*.结核分枝杆菌对氯法齐明耐药的体外诱导实验研究.中国防痨杂志.2015.37(6).632-636.核心期刊 |
80. 杨雯,王彬,郝兰虎,陈效友,陆宇*.滚环扩增技术直接检测痰标本中结核分枝杆菌利福平敏感性的初步研究.中国抗生素杂志.2014.39(11). 849-855.核心期刊 |
81. Dongfeng Zhang, Yang Liu, Chunlin Zhang, Hao Zhang, Bin Wang, Jian Xu, Lei Fu, Dali Yin, Christopher B. Cooper, Zhenkun Ma*, Yu Lu,* and Haihong Huang *.Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents.Molecules.2014.19.4380-4394.SCI |
82. Hongmin Liu, Ju Huang, Jiayang Wang, Minghua Wang, Mingliang Liu, *Bin Wang, Huiyuan Guo, Yu Lu*.Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R,2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.European Journal of Medicinal Chemistry.2014.86(2014).628-638.SCI |
83. Lanhu Hao, Shaochen Guo, Chengcheng Liu, Hui Zhu, Bin Wang, Lei Fu, Mingting Chen, Lin Zhou, Junying Chi, Wen Yang, Wenjuan Nie, Yu Lu*.Comparative bioavailability of rifampicin and isoniazid from fixed dose combinations with separate formulation.International Journal of Tuberculosis and Lung Disease.2014.18(12).1505-1512.SCI |
84. 郭少晨,朱慧,徐建,郝兰虎,王彬,付雷,陈明亭,周林,池俊英, 陆宇*.两种国产抗结核固定剂量复合剂中利福平的药代动力学和生物等效性.中国防痨杂志.2014.36(12).1075-1079.核心期刊 |
85. Jian Xu, Haixia Jin, Hui Zhu, Meiqin Zheng, Bin Wang, Chengcheng Liu, Mingting Chen, Lin Zhou, Weijie Zhao, Lei Fu, Yu Lu*.Oral Bioavailability of Rifampicin, Isoniazid, Ethambutol,and Pyrazinamide in a 4-Drug Fixed-Dose Combination Compared With the Separate Formulations in Healthy Chinese Male Volunteers.Clinical Therapeutic.2013.35(2).161-167.SCI |
86. Meiqin Zheng, Haixia Jin, Lei Fu, Jian Xu, Bin Wang, Weijie Zhao, Hui Zhu,Peng Li, Yu Lu* , Qi Li .A comparative study on the activities of six combination regimens against multidrugresistant Mycobacterium tuberculosis infection in BALB/c mice .Journal of Chemotherapy .2013.25(2).81-86.SCI |
87. Zengquan Wei, Jian Wang, Mingliang Liu,*, Sujie Li, Lanying Sun , Huiyuan Guo, Bin Wang ,Yu Lu* .Synthesis, in Vitro Antimycobacterial and Antibacterial Evaluation of IMB-070593 Derivatives Containing a Substituted Benzyloxime Moiety.Molecules .2013.18.3872-3893.SCI |
88. 刘诚诚,金海霞,徐建,李华,朱慧,付雷,王彬,陆宇*.结核病患者N-乙酰基转移酶2基因型与异烟肼血药浓度关系的研究.中国防痨杂志.2013.35(3).179-182.核心期刊 |
89. 刘诚诚,金海霞,徐建,李华,朱慧,付雷,王彬,陆宇*.结核病患者N-乙酰基转移酶2基因型与异烟肼血药浓度关系的研究.中国防痨杂志.2013.35(3). 179-183.核心期刊 |
90. 朱慧,王彬,付雷,刘诚诚,陆宇*.吡嗪酰胺每日一次与三次给药在小鼠体内的药代动力学比较及其对异烟肼-利福平的影响.中国防痨杂志.2013.35(12).983-988.核心期刊 |
91. 金海霞,付雷,王彬,郑梅秦,陆宇*.结核分枝杆菌利福平依赖性的初步研究.中国防痨杂志.2012.34(10).670-675.核心期刊 |
92. Shuo Wang, Xuedong Jia, Mingliang Liu, Yu Lu*, Huiyuan Guo.Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-sunstituted benzyl moiety.Bioorganic﹠Medicinal Chemistry Letters.2012.15.5971-5975.SCI |
93. Jian Xu, Yu Lu*, Lei Fu, Hui Zhu, Bin Wang, Khisimuzi Mdluli ,Anna M. Upton, Haixia Jin, Meiqin Zheng, Weijie Zhao, Peng Li .In vitro and in vivo activity of clofazimine exhibits activity against Mycobacterium tuberculosis persisters.International Journal of Tuberculosis and Lung Disease.2012.16(8).1119-1125.SCI |
94. Dongfeng Zhang, Yu Lu#, Kai Liu, Binna Liu, Jingbin Wang,Gang Zhang, Hao Zhang, Yang Liu,Bin Wang, Meiqin Zheng, Lei Fu,Yanyan Hou, Ningbo Gong,Yang Lv, Chun Li,Christopher B. Cooper,Anna M. Upton, Dali Yin,Zhenkun Ma, and Haihong Huang.Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis .Joural of Medicinal Chemistry .2012.55.8409−8417 .SCI |
95. 朱慧,李芃,陆宇*.LC - MS/MS 方法同时检测人血浆中异烟肼、乙胺丁醇和吡嗪酰胺的浓度.药物分析杂志.2012.32(6).945-949.核心期刊 |
96. Yu Lu*, Meiqin Zheng, Bin Wang, Lei Fu, Weijie Zhao, Peng Li, Jian Xu, Hui Zhu, Haixia Jin, Dali Yin, Haihong Huang and Zhenkun Ma.Clofazimine Analogs with Efficacy against Drug Sensitive and Drug Resistant Experimental Tuberculosis and Reduced Potential for Tissue Discoloration.Antimicrob Agent and Chemotherapy.2011.vol.55 (11).5185-5193.SCI |
97. 郑梅琴; 付雷; 王彬; 李芃; 陆宇*.豚鼠结核病模型在抗结核新药评价中的应用.临床肺科杂志.2011.16(8).1205-1209.核心期刊 |
98. 郑梅琴; 陆宇*; 王彬; 付雷.Alamar blue法检测药物细胞内抗结核活性的研究 .中国抗生素杂志.2011.36(6).468-471.核心期刊 |
99. 陆宇 ,王彬,赵伟杰,郑梅琴,李芃,付雷,梁博文.氯法齐明与其他抗结核药物联用对结核分枝杆菌的作用.中华结核和呼吸杂志.2010.33(9).675-678.核心期刊 |
100. 徐建 陆宇* 郑梅琴 付雷 赵伟杰 王彬 李芃.气溶胶感染小鼠急性结核病治疗模型的建立及应用.中国防痨杂志.2010.32(8).462-466.核心期刊 |
101. 陆宇,郑梅琴,王彬,赵伟杰,付雷,李芃,梁博文,初乃惠.异烟肼对氯法齐明在小鼠体内组织分布和蓄积的影响.中华结核和呼吸杂志.2009.32(9).694-697.核心期刊 |
102. 郑梅琴,陆宇*,付雷,赵伟杰.MTT法在抗结核新药细胞毒性快速筛选中的应用研究.中国防痨杂志.2009.31(9).530-533.核心期刊 |
103. 陆宇,郑梅琴,王彬,赵伟杰,李芃,初乃惠,梁博文.氯法齐明抗结核分枝杆菌的体内外活性研究.中华结核和呼吸杂志.2008.31(10).752-755.核心期刊 |
104. 陆宇,赵伟杰,郑梅琴,王彬,M. Weisspapir,H. Gao,J . Schwarz.纳米链霉素在小鼠结核病模型中的治疗作用研究.中国防痨杂志.2008.30(6).502-505.核心期刊 |
105. 陆宇,高孟秋,赵伟杰,王彬,马丽萍,朱莉贞.结核分枝杆菌持留状态体内外模型的建立和检测.中华结核和呼吸杂志.2007.30(3).211-215.核心期刊 |
106. 陆宇,王彬,郑梅琴,赵伟杰,李芃.应用Alamar Blue 和MTT对抗结核药物进行最低抑菌浓度测定的研究.中国防痨杂志.2007.29(6).499-501.核心期刊 |
107. 陆宇,高孟秋,初乃惠,马丽萍,朱莉贞.Ag85BmRNA定量检测作为化疗监测指标的初步研究.中国防痨杂志.2005.27(5).281-284.核心期刊 |